Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M34.8Revenue $M1.0Net Margin (%)-3,883.1Altman Z-Score-24.7
Enterprise Value $M25.0EPS $-0.5Operating Margin %-3,908.3Piotroski F-Score5
P/E(ttm)--Beneish M-Score-1.1Pre-tax Margin (%)-3,868.6Higher ROA y-yY
Price/Book4.610-y EBITDA Growth Rate %-16.6Quick Ratio2.3Cash flow > EarningsY
Price/Sales28.25-y EBITDA Growth Rate %-30.3Current Ratio2.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-116.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-452.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M109ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with STEM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

STEM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


STEM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stratton Kenneth BlairGeneral Counsel 2015-12-29Sell104,549$0.45-28.89view

Quarterly/Annual Reports about STEM:

    News about STEM:

    Articles On GuruFocus.com
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    Two Biotech Stocks to Buy, One to Avoid Jan 09 2012 
    StemCells Inc. Reports Operating Results (10-Q) Nov 03 2010 
    StemCells Inc. Reports Operating Results (10-Q) May 04 2010 
    StemCells Inc. Reports Operating Results (10-Q) Nov 05 2009 
    StemCells Inc. Reports Operating Results (10-Q) Aug 10 2009 
    The Next Boom Emerges Nov 23 2008 

    More From Other Websites
    Ian Massey, President and CEO of StemCells, Inc., to Participate on a Regenerative Medicine Panel at... Feb 04 2016
    Endonovo Therapeutics Tops Our List For Investor Potential in Biotechs Jan 28 2016
    CORRECTING and REPLACING -- StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source... Jan 28 2016
    StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source Capital Group’s 2016... Jan 28 2016
    StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source Capital Group’s 2016... Jan 28 2016
    Biotech with deficit, layoffs awards CEO $1 million severance package Jan 20 2016
    3 Stocks Tackling Concussion Issues in Pro Athletes Jan 20 2016
    Bioelectronic-Medicine Leader Endonovo Therapeutics, Inc. Begins 2016 on a Strong Note Jan 19 2016
    STEMCELLS INC Files SEC form 8-K/A, Change in Directors or Principal Officers, Other Events Jan 15 2016
    STEMCELLS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial... Jan 12 2016
    StemCells, Inc. CEO Martin McGlynn Passes Baton to President and COO Ian Massey Jan 11 2016
    StemCells, Inc. to Participate at the 8th Annual Biotech Showcase Investor Conference Jan 06 2016
    StemCells, Inc. to Participate at the 8th Annual Biotech Showcase Investor Conference Jan 06 2016
    Top Analyst Upgrades and Downgrades: Intel, Petrochina, Skullcandy, StemCells, 3D Systems, Rockwell... Dec 30 2015
    [$$] StemCells Stock Could Reach $3 Dec 24 2015
    STEMCELLS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Other Events Dec 24 2015
    StemCells, Inc. Announces Strategic Realignment Dec 23 2015
    StemCells, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 16 2015
    STEMCELLS INC Financials Dec 08 2015
    Maxim Group's Jason Kolbert and Jason McCarthy Interviewed by The Life Sciences Report Dec 08 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK